Invuity Announces Full Commercial Launch of PhotonBlade™
September 25 2017 - 4:01PM
Invuity, Inc. (NASDAQ:IVTY), a leading medical technology
company focused on minimal access surgery, today announced the
reintroduction and full commercial launch of PhotonBlade™, a
dynamic precision illuminator with enhanced energy. This
version of PhotonBlade includes enhancements to improve energy
delivery and optimize illumination performance. The Company
anticipates shipping product to customers in the next few
weeks.
PhotonBlade represents a new technology platform for Invuity,
delivering directed, thermally cool illumination at the precise
point of surgical treatment. PhotonBlade’s novel energy design
consists of a proprietary insulated blade for precise cutting and
coagulation of tissue, with minimal effect on adjacent tissue. This
sophisticated illumination technology does not require a
proprietary generator, thereby leveraging widely available
operating room equipment and avoiding an institutional capital
investment.
“We are pleased that PhotonBlade has transitioned to full
commercial launch and we look forward to providing our clinicians
with this technology to better treat their patients,”said Invuity
Chief Executive Officer Philip Sawyer. “PhotonBlade exemplifies the
company’s strong commitment to providing a broad array of
innovative solutions to our customers.”
About Invuity®Invuity, Inc. is a leading
medical technology company focused on developing and marketing
advanced surgical devices to improve the ability of physicians to
perform minimal access surgery through smaller and hidden
incisions. The company's patented Intelligent Photonics® technology
delivers enhanced visualization which facilitates surgical
precision, efficiency and safety. In addition, the company utilizes
comprehensive strategic marketing programs to create stronger
institutional partnerships. Clinical applications include women’s
health, encompassing breast cancer and breast reconstruction
surgery, gynecology and thyroid surgery. Additional
applications include procedures for electrophysiology, spine,
orthopedic, cardiothoracic, and general
surgery. Invuity is headquartered in San Francisco,
CA. For more information, visit www.invuity.com.
Forward-Looking StatementsThis announcement
contains forward-looking statements that involve risks and
uncertainties, including statements regarding the anticipated
timing of PhotonBlade shipments. Actual results could differ
materially from those projected in the forward-looking statements
as a result of certain risk factors, including, but not limited to:
the Company’s ability to complete the PhotonBlade shipping process
in the specified time period. The Company undertakes no obligation
to update the forward-looking information in this release. More
information about potential factors that could affect the Company's
business and financial results is included in its filings with the
Securities and Exchange Commission, including, without limitation,
under the captions: "Management's Discussion and Analysis of
Financial Condition and Results of Operations," and "Risk Factors,"
which are on file with the Securities and Exchange Commission.
CONTACT:Company Contact:Jim MackanessChief Financial
OfficerInvuity, Inc.415-655-2129
Investors:Mark KlausnerWestwicke
Partners443-213-0501irdept@invuity.com
INVUITY, INC. (NASDAQ:IVTY)
Historical Stock Chart
From Jun 2024 to Jul 2024
INVUITY, INC. (NASDAQ:IVTY)
Historical Stock Chart
From Jul 2023 to Jul 2024